China Universal Asset Management »

Lexicon Pharmaceuticals shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Lexicon Pharmaceuticals (LXRX) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Lexicon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Lexicon Pharmaceuticals held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexicon Pharmaceuticals by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $113k 47k 2.41
2023-12-31 $43k 28k 1.52
2023-09-30 $7.0k 6.3k 1.11
2023-06-30 $6.0k 2.5k 2.41
2023-03-31 $6.0k 2.6k 2.35
2022-12-31 $4.0k 1.9k 2.09
2022-09-30 $4.0k 1.7k 2.33

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding Lexicon Pharmaceuticals

Artal Group
BVF
Vanguard Group
Jpmorgan Chase & Co
NEA Management Company
Gail Mannix
Millennium Management
Citadel Advisors
Charles Schwab Investment Management
GSA Capital Partners
D. E. Shaw & Co
Bank of New York Mellon
Connor, Clark & Lunn Investment Management
Jane Street
Virtus ETF Advisers

View all funds holding Lexicon Pharmaceuticals